VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 676 filers reported holding VANECK VECTORS ETF TR in Q3 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $268,252 | -73.4% | 8,292 | -77.5% | 0.01% | -77.1% |
| Q2 2022 | $1,008,000 | +227.3% | 36,817 | +199.0% | 0.05% | +242.9% |
| Q3 2021 | $308,000 | -59.0% | 12,315 | -44.4% | 0.01% | -62.2% |
| Q2 2021 | $752,000 | +113.0% | 22,139 | +110.9% | 0.04% | +85.0% |
| Q1 2021 | $353,000 | -42.8% | 10,499 | -38.7% | 0.02% | -55.6% |
| Q4 2020 | $617,000 | -35.3% | 17,117 | -29.7% | 0.04% | -47.1% |
| Q3 2020 | $954,000 | +225.6% | 24,358 | +205.4% | 0.08% | +193.1% |
| Q2 2020 | $293,000 | +13.6% | 7,976 | -9.5% | 0.03% | -9.4% |
| Q4 2019 | $258,000 | +8.9% | 8,813 | -0.8% | 0.03% | -13.5% |
| Q3 2019 | $237,000 | -29.9% | 8,883 | -32.8% | 0.04% | -35.1% |
| Q2 2019 | $338,000 | -54.4% | 13,221 | -60.0% | 0.06% | -49.6% |
| Q1 2019 | $741,000 | +8133.3% | 33,068 | +187.5% | 0.11% | +3666.7% |
| Q4 2017 | $9,000 | – | 11,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |